1. Home
  2. TEVA vs MKC Comparison

TEVA vs MKC Comparison

Compare TEVA & MKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • MKC
  • Stock Information
  • Founded
  • TEVA 1901
  • MKC 1889
  • Country
  • TEVA Israel
  • MKC United States
  • Employees
  • TEVA N/A
  • MKC N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • MKC Packaged Foods
  • Sector
  • TEVA Health Care
  • MKC Consumer Staples
  • Exchange
  • TEVA Nasdaq
  • MKC Nasdaq
  • Market Cap
  • TEVA 23.7B
  • MKC 20.1B
  • IPO Year
  • TEVA N/A
  • MKC N/A
  • Fundamental
  • Price
  • TEVA $16.75
  • MKC $80.14
  • Analyst Decision
  • TEVA Strong Buy
  • MKC Buy
  • Analyst Count
  • TEVA 6
  • MKC 8
  • Target Price
  • TEVA $24.17
  • MKC $83.75
  • AVG Volume (30 Days)
  • TEVA 15.5M
  • MKC 1.8M
  • Earning Date
  • TEVA 01-29-2025
  • MKC 03-25-2025
  • Dividend Yield
  • TEVA N/A
  • MKC 2.25%
  • EPS Growth
  • TEVA N/A
  • MKC 15.87
  • EPS
  • TEVA N/A
  • MKC 2.92
  • Revenue
  • TEVA $16,544,000,000.00
  • MKC $6,723,700,000.00
  • Revenue This Year
  • TEVA $5.31
  • MKC $2.25
  • Revenue Next Year
  • TEVA $1.18
  • MKC $3.53
  • P/E Ratio
  • TEVA N/A
  • MKC $27.45
  • Revenue Growth
  • TEVA 4.40
  • MKC 0.92
  • 52 Week Low
  • TEVA $12.51
  • MKC $66.88
  • 52 Week High
  • TEVA $22.80
  • MKC $85.49
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 35.64
  • MKC 63.30
  • Support Level
  • TEVA $16.08
  • MKC $75.66
  • Resistance Level
  • TEVA $17.63
  • MKC $78.50
  • Average True Range (ATR)
  • TEVA 0.54
  • MKC 1.47
  • MACD
  • TEVA 0.01
  • MKC 0.29
  • Stochastic Oscillator
  • TEVA 39.82
  • MKC 95.32

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About MKC McCormick & Company Incorporated

In its 135-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. And its reach is extensive, with nearly 40% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.

Share on Social Networks: